Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with a Body Mass Index (BMI) of 30 or higher (a measure of body weight relative to height)
- Women with a waist measurement of 88 cm or more, or men with a waist measurement of 102 cm or more
Who may not be able to join:
- People whose body weight has changed by more than 5% in the past six months (i.e., weight has not been stable)
- People with a known heart, neurological, kidney, liver, or metabolic condition (such as diabetes)
- People with currently uncontrolled high blood pressure, specifically Stage 2 hypertension (blood pressure above 140/90 mmHg) — note that blood pressure medication is permitted
- People diagnosed with obstructive sleep apnea (a sleep condition affecting breathing)
- People who have previously had weight-loss (bariatric) surgery
- People diagnosed with, or showing signs of, an airway or lung disease
- People who currently use, or have regularly used in the past 6 months, tobacco or nicotine products such as cigarettes or vaping devices
- Women who are pregnant, breastfeeding, or post-menopausal (all self-reported; pregnancy also confirmed by a urine test)
- People who are currently incarcerated
- People who have recently had abdominal surgery or have an abdominal hernia
- People with asthma who have very low awareness of their own symptoms, frequent severe episodes, or an unusually low sense of breathlessness
- People with a ruptured eardrum or other ear conditions
- People with significantly elevated pressure or volume in the left side of the heart (confirm with trial site)
- People whose heart failure symptoms have worsened during breathing training
- People currently experiencing a cold, sinus infection, or respiratory tract infection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Joseph C Watso, PhD, Florida State University
Phone: 9522121833
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in middle cerebral artery blood velocity reactivity to hypercapnia
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.